Claritin Sales Raise Questions About Growth Opportunities For Switches
This article was originally published in The Tan Sheet
Executive Summary
Sales of Schering-Plough's Claritin are already lagging in the first quarter compared to the same period last year
You may also be interested in...
Claritin Growth Plateaus As Schering Moves Ahead With Consent Decree
Sales of Schering-Plough's Claritin (loratadine) appear to have leveled off following a strong 2003 campaign for the over-the-counter antihistamine
Claritin Growth Plateaus As Schering Moves Ahead With Consent Decree
Sales of Schering-Plough's Claritin (loratadine) appear to have leveled off following a strong 2003 campaign for the over-the-counter antihistamine
Claritin Growth Plateaus As Schering Moves Ahead With Consent Decree
Sales of Schering-Plough's Claritin (loratadine) appear to have leveled off following a strong 2003 campaign for the over-the-counter antihistamine